2020年8月7日 · Results: Fourteen participants were selected based on known clinical expertise in critical care and in providing respiratory support with ECCO 2 R or extracorporeal membrane oxygenation. ARDS was considered the primary indication for ECCO 2 R therapy (n = 7), while 3 participants considered ae-COPD the primary indication.

2020年8月7日 · In patients with acute respiratory distress syndrome (ARDS), ECCO 2 R therapy may be used to allow ultra-protective lung ventilation (UPLV) and reduce ventilator-induced lung injury (VILI) by decreasing tidal volume (VT), both plateau (Pplat) and driving pressures and respiratory rate, while also controlling respiratory acidosis [5, 6, 7, 8, 9, ...

2024年4月30日 · The three available RCTs did not demonstrate an effect on mortality, but a significantly longer ICU and hospital stay associated with ECCO2R. ECCO2R effectively reduces PaCO2 and acidosis allowing for less invasive ventilation.

2022年6月1日 · Extracorporeal CO 2 removal (ECCO 2 R) is a better alternative to ECMO for treating refractory hypercapnia in acute respiratory failure. ECCO 2 R is less invasive and complex than ECMO because it utilizes significantly …

Extracorporeal carbon dioxide removal (ECCO 2 R) therapy removes CO 2 from a patient’s blood with an extracorporeal circuit to effectively manage acute hypercapnia and respiratory acidosis that can result from lung-protective mechanical ventilation strategies. See how PrismaLung+ enables ECCO 2 R therapy.

2012年9月21日 · Extracorporeal carbon dioxide removal has the potential to optimize lung protective ventilation by uncoupling oxygenation and carbon dioxide clearance. The aim of this article is to review the carbon dioxide removal strategies that …

2020年8月7日 · 最新在Critical Care 发表的论文“ECCO2R therapy in the ICU: consensus of a European round table meeting”阐明了重症监护室中的ECCO2R治疗。 欧洲ECCO2R专家圆桌会议就此召开，以进一步探索这种治疗方法的潜力。 本文采用基于德尔菲的改良方法整理欧洲专家的意见，以更好地了解ECCO2R治疗的应用方式，确定如何选择患者和如何做出治疗决策，以及确定任何共识点。 结果显示根据已知的重症监护和使用ECCO2R或体外膜氧合提供呼吸支持的临床 …

体外二氧化碳清除（ECCO 2 R）是一种体外生命支持技术，通过体外膜肺（“人工肺”）清除机体过多产生的二氧化碳（CO 2），以降低患者通气需求和呼吸机支持水平。 随着体外生命支持相关技术的改进和临床经验的增多，最近研究提示ECCO 2 R在多种重症场景中具有重要的潜在价值，但亟待大样本临床研究进一步规范其临床指征及其床旁管理。 本文通过文献复习和笔者经验，综述了ECCO 2 R在急性呼吸窘迫综合征（ARDS）、慢性阻塞性肺疾病急性加重（AECOPD）、肺移 …

2020年8月7日 · Data show that in patients with COVID-19–induced ARDS and AKI, ECCO2R-plus-RRT is effective in allowing ultraprotective ventilator settings while maintaining an effective support of renal function and values of pH within physiologic limits.

2021年8月30日 · Conclusion: ECCO2R therapy significantly improved survival, iMV duration and LOS in patients with severe HRF due to COPD or ARDS, and successfully provided LPV approaches. Further studies are needed to assess promising benefits of ECCO2R therapy.